- 商品介绍
- 规格参数
- 包装参数
|
规格 |
|
| Assay Category: | Biochemical Assay |
| Druggable Target: | Nuclear Receptors |
| Label or Dye: | Tb (Terbium) |
| Product Line: | LanthaScreen® |
| Readout: | TR-FRET (Activity) |
| Technique: | TR-FRET |
| Validated Application: | Nuclear Receptor Assay |
| Color: | Green |
| Detection Method: | Fluorescent |
| For Use With (Equipment): | Microplate Reader |
| Format: | 384-well plate |
|
储存 |
|
|
Tb-anti-GST Antibody (Rabbit): Store at -20 °C FXR-LBD, GST: Store at -80 °C Fluoroscein Coactivator Peptide: Store at -20 °C TR-FRET Coregulatore Buffer G: Store at 4 °C 1M DTT: Store at -20 °C or -80 °C |
|
描述 |
This kit contains Rabbit Tb-Anti-GST antibody; other kit components are the same as kit PV4833:
The LanthaScreen® TR-FRET FXR (farnesoid X receptor) Coactivator Assay Kit provides a sensitive and robust method for high-throughput screening of potential FXR ligands as agonists of coactivator recruitment. The kit uses a terbium (Tb)-labeled anti-GST antibody, a fluorescein- labeled coactivator peptide, and an FXR ligand-binding domain (FXR-LBD) that is tagged with glutathione-S-transferase (GST), in a homogeneous, mix-and-read assay format.
To assay:
When running the LanthaScreen® TR-FRET FXR coactivator assay in agonist mode, FXR-LBD is added to ligand test compounds followed by addition of a mixture of the fluorescein-coactivator peptide and Tb-labeled anti-GST antibody. After an incubation period at room temperature, the 520 nm/495 nm TR-FRET ratio is calculated and used to determine the EC50 from a dose response curve of the compound. Based on the biology of the FXR-coactivator peptide interaction, the ligand EC50 is a composite value representing the amount of ligand required to bind to receptor, effect a conformational change, and recruit coactivator peptide (Figure 1).
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |



微信小程序
7X24小时在线咨询